file1
,
file2
, etc. all in the same folder or directory;
first, locate one of the files with the [Browse...] button. Then alter the
file path in the box above to include '*' character (eg. file*
).
Wildcard '?' to blanket only one character works too.Historiographs |
Grand Totals: LCS 17722, GCS 106366, CR 136943 Collection span: 1963 - 2012 | |
Word(i) List (4568) Word count: 24159, All words count: 34321 |
# | Word | Recs | TLCS | TGCS |
---|---|---|---|---|
2601 | EDENTULOUS | 1 | 1 | 18 |
2602 | ELECTROSPRAY-IONIZATION | 1 | 0 | 18 |
2603 | ERYTHROPOIETIN | 2 | 0 | 18 |
2604 | ESTABLISHING | 3 | 8 | 18 |
2605 | FACILITATING | 2 | 5 | 18 |
2606 | FIBERS | 1 | 1 | 18 |
2607 | FINE | 1 | 12 | 18 |
2608 | GRANZYMES | 1 | 1 | 18 |
2609 | HISTOLOGIC | 1 | 5 | 18 |
2610 | HISTOMETRIC | 1 | 1 | 18 |
2611 | I-131-FIBRINOGEN | 1 | 0 | 18 |
2612 | II-EXPRESSING | 1 | 1 | 18 |
2613 | IN-UTERO | 1 | 1 | 18 |
2614 | INCLUSION | 1 | 1 | 18 |
2615 | INDIRECT | 2 | 3 | 18 |
2616 | IRRADIATIION | 1 | 0 | 18 |
2617 | KUPFFER | 4 | 4 | 18 |
2618 | LIFE-THREATENING | 1 | 7 | 18 |
2619 | LIVER-ASSOCIATED | 1 | 5 | 18 |
2620 | LOADING | 1 | 0 | 18 |
2621 | LONGITUDINAL | 2 | 0 | 18 |
2622 | LYMPH-NODE | 1 | 1 | 18 |
2623 | MDL | 1 | 0 | 18 |
2624 | MEDIATE | 2 | 0 | 18 |
2625 | MIGRATION-INHIBITORY | 1 | 0 | 18 |
2626 | MOTILITY | 1 | 0 | 18 |
2627 | MUCOSAL | 2 | 1 | 18 |
2628 | OLD | 2 | 5 | 18 |
2629 | PERFORIN | 1 | 1 | 18 |
2630 | PERFUSATE | 1 | 5 | 18 |
# | Word | Recs | TLCS | TGCS |
2631 | PERIPANCREATIC | 1 | 1 | 18 |
2632 | PNEUMATICALLY | 1 | 0 | 18 |
2633 | PROPOSAL | 1 | 4 | 18 |
2634 | REQUIRE | 1 | 1 | 18 |
2635 | RESERVE | 1 | 0 | 18 |
2636 | RIDGE | 1 | 1 | 18 |
2637 | SERUM-ALBUMIN | 1 | 0 | 18 |
2638 | SICKNESS | 1 | 0 | 18 |
2639 | STEM-CELL | 1 | 1 | 18 |
2640 | STZ-INJECTED | 1 | 0 | 18 |
2641 | TACROLIMUS-RELATED | 1 | 0 | 18 |
2642 | TRANSPLANT-RELATED | 1 | 5 | 18 |
2643 | VASCULOPATHY | 2 | 1 | 18 |
2644 | VASORELAXATION | 1 | 0 | 18 |
2645 | VOLTAGE-OPERATED | 1 | 0 | 18 |
2646 | ALLO-MHC | 1 | 7 | 17 |
2647 | ALLOANTIBODY | 2 | 4 | 17 |
2648 | ALLORECOGNITION | 2 | 2 | 17 |
2649 | ALPHA-1-ANTITRYPSIN | 1 | 0 | 17 |
2650 | ANTIGEN-STIMULATED | 1 | 0 | 17 |
2651 | ANTIREJECTION | 2 | 3 | 17 |
2652 | ARRAY | 1 | 1 | 17 |
2653 | BCL-X | 1 | 0 | 17 |
2654 | CD54 | 2 | 0 | 17 |
2655 | CHALLENGE | 4 | 0 | 17 |
2656 | CONTROLLING | 1 | 0 | 17 |
2657 | DAMAGED | 1 | 1 | 17 |
2658 | DECISION | 2 | 1 | 17 |
2659 | DESORPTION | 1 | 0 | 17 |
2660 | DIFFICULTIES | 1 | 0 | 17 |
# | Word | Recs | TLCS | TGCS |
2661 | DIRECTED | 2 | 0 | 17 |
2662 | ELONGATION | 1 | 3 | 17 |
2663 | EXCRETORY | 1 | 3 | 17 |
2664 | FILTER | 1 | 2 | 17 |
2665 | FLAP | 2 | 5 | 17 |
2666 | FRONTIERS | 2 | 1 | 17 |
2667 | GOING | 1 | 0 | 17 |
2668 | GREENFIELD | 2 | 2 | 17 |
2669 | HYPERTENSINOGENIC | 1 | 0 | 17 |
2670 | IMPLICATION | 2 | 1 | 17 |
2671 | INDEPENDENT | 1 | 0 | 17 |
2672 | ION | 1 | 0 | 17 |
2673 | IONIZATION | 1 | 0 | 17 |
2674 | ISCHEMICALLY | 1 | 1 | 17 |
2675 | KINASE | 1 | 3 | 17 |
2676 | LASER | 1 | 0 | 17 |
2677 | LIPOSOME-INCORPORATED | 1 | 3 | 17 |
2678 | MASS | 1 | 0 | 17 |
2679 | MATRIX-ASSISTED | 1 | 0 | 17 |
2680 | MICROSOMES | 4 | 3 | 17 |
2681 | MORPHOLOGIC | 1 | 3 | 17 |
2682 | MURAMIDASE | 1 | 0 | 17 |
2683 | MYCOPHENOLIC | 1 | 0 | 17 |
2684 | NECESSARY | 1 | 1 | 17 |
2685 | NEURITE | 1 | 3 | 17 |
2686 | OBESITY | 1 | 0 | 17 |
2687 | OINTMENT | 1 | 2 | 17 |
2688 | ORDERED | 1 | 1 | 17 |
2689 | OSTEOMYOCUTANEOUS | 2 | 5 | 17 |
2690 | P23 | 1 | 3 | 17 |
# | Word | Recs | TLCS | TGCS |
2691 | PAIRS | 2 | 0 | 17 |
2692 | PHAGOCYTES | 1 | 0 | 17 |
2693 | PHYTOHEMAGGLUTININ | 2 | 3 | 17 |
2694 | POLARIZES | 1 | 0 | 17 |
2695 | POTENTIALS | 1 | 0 | 17 |
2696 | PREDICTOR | 1 | 0 | 17 |
2697 | PROMISES | 1 | 0 | 17 |
2698 | REAPPRAISAL | 2 | 5 | 17 |
2699 | RED | 3 | 0 | 17 |
2700 | REQUIRES | 1 | 3 | 17 |
2701 | SEVEN | 1 | 4 | 17 |
2702 | SIGNAL-REGULATED | 1 | 3 | 17 |
2703 | SILIBININ | 1 | 0 | 17 |
2704 | SPECTROMETRY | 1 | 0 | 17 |
2705 | SUBCUTANEOUS | 2 | 0 | 17 |
2706 | SUBTHERAPEUTIC | 1 | 0 | 17 |
2707 | SYNTHASE | 3 | 0 | 17 |
2708 | THMECTOMIZED | 1 | 1 | 17 |
2709 | THROMBUS | 1 | 8 | 17 |
2710 | TWENTY | 2 | 0 | 17 |
2711 | UROGRAPHY | 1 | 3 | 17 |
2712 | ABROGATES | 2 | 6 | 16 |
2713 | AMERICAN | 1 | 4 | 16 |
2714 | ANASTOMOSIS | 3 | 2 | 16 |
2715 | ANIMAL-MODELS | 1 | 1 | 16 |
2716 | ANTI-MOUSE | 1 | 2 | 16 |
2717 | ANTIBIOTIC | 1 | 0 | 16 |
2718 | ANTITHROMBOTIC | 1 | 0 | 16 |
2719 | ASYMMETRIC | 1 | 0 | 16 |
2720 | ATTITUDES | 1 | 0 | 16 |
# | Word | Recs | TLCS | TGCS |
2721 | AUTOIMMUNE-PRONE | 1 | 1 | 16 |
2722 | AUTOPSY | 1 | 0 | 16 |
2723 | AUTOTRANSPLANTED | 2 | 0 | 16 |
2724 | B-LYMPHOCYTES | 2 | 1 | 16 |
2725 | BALB | 1 | 2 | 16 |
2726 | CADAVERS | 1 | 2 | 16 |
2727 | CHARACTERIZED | 1 | 1 | 16 |
2728 | COVERAGE | 1 | 0 | 16 |
2729 | CTLS | 1 | 3 | 16 |
2730 | DELTA | 1 | 2 | 16 |
2731 | DERMATOSES | 1 | 1 | 16 |
2732 | DSG | 1 | 1 | 16 |
2733 | EFFERENT | 1 | 8 | 16 |
2734 | ENERGY | 2 | 1 | 16 |
2735 | ETHICS | 1 | 0 | 16 |
2736 | EXPECTATIONS | 2 | 1 | 16 |
2737 | FACTOR-SECRETING | 1 | 0 | 16 |
2738 | HAZARDOUS | 1 | 1 | 16 |
2739 | HEART-BEATING | 1 | 0 | 16 |
2740 | HEMATOLOGICAL | 2 | 4 | 16 |
2741 | HETEROTOPIC | 3 | 1 | 16 |
2742 | HINDLIMB | 2 | 6 | 16 |
2743 | HORMONAL | 1 | 0 | 16 |
2744 | HYPERIMMUNIZED | 2 | 0 | 16 |
2745 | HYPOTHERMIC | 1 | 0 | 16 |
2746 | IATROGENICALLY | 1 | 12 | 16 |
2747 | IMMUNE-RESPONSES | 1 | 8 | 16 |
2748 | LANDMARK | 2 | 2 | 16 |
2749 | LOGISTICS | 1 | 0 | 16 |
2750 | LPR | 1 | 1 | 16 |
# | Word | Recs | TLCS | TGCS |
2751 | MAINTAIN | 3 | 5 | 16 |
2752 | MP-LPR | 1 | 1 | 16 |
2753 | MRL | 1 | 1 | 16 |
2754 | NEPHROLOGY | 3 | 1 | 16 |
2755 | NEWBORN | 3 | 3 | 16 |
2756 | NITRIC | 3 | 0 | 16 |
2757 | NON | 1 | 0 | 16 |
2758 | OXIDE | 3 | 0 | 16 |
2759 | PHAGOCYTOSIS | 2 | 1 | 16 |
2760 | PLACENTAL | 1 | 1 | 16 |
2761 | PREECLAMPSIA | 1 | 1 | 16 |
2762 | PROTHROMBOTIC | 1 | 0 | 16 |
2763 | PSYCHOLOGICAL-ASPECTS | 1 | 0 | 16 |
2764 | REARRANGEMENT | 2 | 4 | 16 |
2765 | RECEIVED | 1 | 0 | 16 |
2766 | SHORTAGE | 2 | 0 | 16 |
2767 | SIGNIFICANTLY | 1 | 2 | 16 |
2768 | TRANSIENTLY | 1 | 5 | 16 |
2769 | VARIATION | 4 | 1 | 16 |
2770 | VENUE | 1 | 5 | 16 |
2771 | VETERANS | 1 | 4 | 16 |
2772 | WAITING | 1 | 7 | 16 |
2773 | XENOGRAFTING | 1 | 0 | 16 |
2774 | 1A-31A | 1 | 1 | 15 |
2775 | ABROGATION | 1 | 6 | 15 |
2776 | ALCOHOLIC | 1 | 5 | 15 |
2777 | ALLOANTIGENS | 4 | 3 | 15 |
2778 | ALP | 1 | 8 | 15 |
2779 | ANTIBIOTIC-TREATMENT | 1 | 0 | 15 |
2780 | ANTICOMPLEMENT | 1 | 0 | 15 |
# | Word | Recs | TLCS | TGCS |
2781 | ANTITOXINS | 1 | 0 | 15 |
2782 | ATTEMPTS | 2 | 1 | 15 |
2783 | B-LYMPHOPROLIFERATIVE | 1 | 3 | 15 |
2784 | BIOASSAYED | 1 | 6 | 15 |
2785 | BP-12 | 1 | 1 | 15 |
2786 | CANDIDACY | 1 | 5 | 15 |
2787 | CHILD | 2 | 7 | 15 |
2788 | COMPARATIVE-STUDIES | 1 | 1 | 15 |
2789 | CONTAIN | 1 | 2 | 15 |
2790 | COOH | 1 | 0 | 15 |
2791 | DIABETOGENIC | 1 | 2 | 15 |
2792 | EVALUATE | 1 | 6 | 15 |
2793 | FACTOR-ALPHA | 1 | 0 | 15 |
2794 | GLYCEMIC | 1 | 0 | 15 |
2795 | IMMUNO-SUPPERSSION | 1 | 6 | 15 |
2796 | JOURNEY | 2 | 3 | 15 |
2797 | K76 | 1 | 0 | 15 |
2798 | NEPHROPATHY | 2 | 0 | 15 |
2799 | PASSIVELY | 2 | 1 | 15 |
2800 | PIG-TO-RAT | 1 | 0 | 15 |